Science

Shankar Siva: Dose-Escalated Stereotactic Versus Conventional Radiotherapy for Painful Bone Metastases

Shankar Siva/iconcancercentre.com.au

May 11, 2025, 15:32

Shankar Siva: Dose-Escalated Stereotactic Versus Conventional Radiotherapy for Painful Bone Metastases

Shankar Siva, Radiation Oncologist at Peter MacCallum Cancer Centre, shared a post on X:

” New in Journal of Clinical Oncology – ROBOMET

SABR vs standard radiotherapy for painful bone mets.

Pain relief at 1 month:

SABR (20 Gy single dose): 37% complete response

versus (8 Gy): 25% complete response

at 3-months withSABR: 54% vs 31%, p= .048″

Title: Dose-Escalated Stereotactic Versus Conventional Radiotherapy for Painful Bone Metastases (ROBOMET): A Multicenter, Patient-Blinded Randomized Clinical Trial

Authors: Carole Mercier, Charlotte Billiet, Katrien Vandecasteele, Geert De Kerf, Michaël Claessens, Steven Van Laere, Peter Vermeulen, Luc Dirix, Yolande Lievens, Dirk Verellen, Piet Dirix

You can read the Full Article on Journal of Clinical Oncology

Shankar Siva

More posts featuring Shankar Siva.

bone metastases cancer Carole Mercier Charlotte Billiet Conventional Radiotherapy Dirk Verellen Geert De Kerf Journal of Clinical Oncology Katrien Vandecasteele Luc Dirix Michaël Claessens OncoDaily Oncology Peter Vermeulen Piet Dirix radiotherapy ROBOMET Shankar Siva Stereotactic Radiotherapy Steven Van Laere Yolande Lievens

15 Posts Not to Miss from the 3rd Day of ASCO 2025

MATTERHORN Trial at ASCO 2025: Durvalumab plus FLOT Shows Significant Improvement of EFS in Resectable Gastric and GEJ Cancer Treatment

15 Posts Not to Miss from the 2nd Day of ASCO 2025

15 Posts Not to Miss from the 1st Day of ASCO 2025

Wafik El-Deiry: Inside Yvonne Award Ceremony 2025